Risk factors and treatment for recurrent vulvar squamous cell carcinoma.

[1]  F. Ghezzi,et al.  Predictors and Patterns of Local, Regional, and Distant Failure in Squamous Cell Carcinoma of the Vulva , 2017, American journal of clinical oncology.

[2]  A. Lockhart,et al.  The Human Papillomavirus Vaccine: Current Perspective and Future Role in Prevention and Treatment of Anal Intraepithelial Neoplasia and Anal Cancer. , 2016, The oncologist.

[3]  D. Provencher,et al.  Sentinel nodes in vulvar cancer: Long-term follow-up of the GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V) I. , 2016, Gynecologic oncology.

[4]  A. V. D. Van Der Zee,et al.  Repeat sentinel lymph node procedure in patients with recurrent vulvar squamous cell carcinoma is feasible. , 2016, Gynecologic oncology.

[5]  J. Bornstein,et al.  The 2015 International Society for the Study of Vulvovaginal Disease (ISSVD) Terminology of Vulvar Squamous Intraepithelial Lesions , 2016, Obstetrics and gynecology.

[6]  D. Provencher,et al.  Sentinel nodes in vulvar cancer: Long-term follow-up of the GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V) I. , 2016, Gynecologic oncology.

[7]  A. Günthert,et al.  Should Groin Recurrence Still Be Considered as a Palliative Situation in Vulvar Cancer Patients?: A Brief Report , 2015, International Journal of Gynecologic Cancer.

[8]  N. Hacker,et al.  Cancer of the vulva , 2012, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[9]  S. Post,et al.  Perineural Invasion Is an Independent Pathologic Indicator of Recurrence in Vulvar Squamous Cell Carcinoma , 2015, The American journal of surgical pathology.

[10]  M. Rajagopalan,et al.  Impact of adjuvant chemotherapy with radiation for node-positive vulvar cancer: A National Cancer Data Base (NCDB) analysis. , 2015, Gynecologic oncology.

[11]  P. Hillemanns,et al.  Adjuvant Therapy in Lymph Node–Positive Vulvar Cancer: The AGO-CaRE-1 Study , 2015, Journal of the National Cancer Institute.

[12]  G. Fleuren,et al.  CDKN2A(p16) and HRAS are frequently mutated in vulvar squamous cell carcinoma. , 2014, Gynecologic oncology.

[13]  FIGO staging for carcinoma of the vulva, cervix, and corpus uteri , 2014, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[14]  H. V. van Doorn,et al.  Lymph Node Count at Inguinofemoral Lymphadenectomy and Groin Recurrences in Vulvar Cancer , 2014, International Journal of Gynecologic Cancer.

[15]  H. Mackay,et al.  Systemic therapy in squamous cell carcinoma of the vulva: current status and future directions. , 2014, Gynecologic oncology.

[16]  Elsa Alcoba,et al.  An analysis of reported independent prognostic factors for survival in squamous cell carcinoma of the vulva: is tumor size significance being underrated? , 2014, Gynecologic oncology.

[17]  A. Kataki,et al.  Prognosis of vulval cancer with lymph node status and size of primary lesion: A survival study , 2014, Journal of mid-life health.

[18]  H. Minakawa,et al.  The posterior thigh flap revisited: clinical use in oncology patients , 2014, Surgery Today.

[19]  S. Kehoe,et al.  Should pelvic exenteration for symptomatic relief in gynaecology malignancies be offered? , 2014, Archives of Gynecology and Obstetrics.

[20]  L. Kiemeney,et al.  Trends in incidence and survival of Dutch women with vulvar squamous cell carcinoma. , 2013, European journal of cancer.

[21]  M. Solomon,et al.  Pelvic exenteration for recurrent squamous cell carcinoma of the pelvic organs arising from the cloaca – a single institution's experience over 16 years , 2013, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[22]  N. T. Ter Haar,et al.  Spindle cell morphology is related to poor prognosis in vulvar squamous cell carcinoma , 2013, British Journal of Cancer.

[23]  R. Berkowitz,et al.  Relationship of margin status and radiation dose to recurrence in post-operative vulvar carcinoma. , 2013, Gynecologic oncology.

[24]  A. Perrone,et al.  Electrochemotherapy can be used as palliative treatment in patients with repeated loco-regional recurrence of squamous vulvar cancer: a preliminary study. , 2013, Gynecologic oncology.

[25]  L. Torezan,et al.  Cutaneous field cancerization: clinical, histopathological and therapeutic aspects* , 2013, Anais brasileiros de dermatologia.

[26]  D. Heron,et al.  Preoperative intensity modulated radiation therapy and chemotherapy for locally advanced vulvar carcinoma: analysis of pattern of relapse. , 2013, International journal of radiation oncology, biology, physics.

[27]  R. Rocha,et al.  Does the count after inguinofemoral lymphadenectomy in vulvar cancer correlate with outcome? , 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[28]  F. Elgh,et al.  Human Papillomavirus (HPV) and HPV 16–Variant Distribution in Vulvar Squamous Cell Carcinoma in Sweden , 2012, International Journal of Gynecologic Cancer.

[29]  U. Matulonis,et al.  Phase II trial of erlotinib in women with squamous cell carcinoma of the vulva. , 2012, Gynecologic oncology.

[30]  K. Aben,et al.  Successful centralisation of patients with vulvar carcinoma: a population-based study in The Netherlands. , 2012, European journal of cancer.

[31]  A. Gadducci,et al.  Clinico-pathological and biological prognostic variables in squamous cell carcinoma of the vulva. , 2012, Critical reviews in oncology/hematology.

[32]  L. Woelber,et al.  Prognostic Role of Lymph Node Metastases in Vulvar Cancer and Implications for Adjuvant Treatment , 2012, International Journal of Gynecologic Cancer.

[33]  E. van Limbergen,et al.  Pelvic Exenterations for Gynecological Malignancies: A Study of 36 Cases , 2012, International Journal of Gynecologic Cancer.

[34]  H. Michael,et al.  A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a gynecologic oncology group study. , 2011, Gynecologic oncology.

[35]  Jacques Ferlay,et al.  The global burden of cancers attributable to infections in the year 2008: a review and synthetic analysis Web appendix section , 2012 .

[36]  S. Regauer.  Residual anogenital lichen sclerosus after cancer surgery has a high risk for recurrence: a clinicopathological study of 75 women. , 2011, Gynecologic oncology.

[37]  J. Ordi,et al.  Does human papillomavirus infection imply a different prognosis in vulvar squamous cell carcinoma? , 2011, Gynecologic oncology.

[38]  Naveena Singh,et al.  Is Differentiated Vulval Intraepithelial Neoplasia the Precursor Lesion of Human Papillomavirus-Negative Vulval Squamous Cell Carcinoma? , 2011, International Journal of Gynecologic Cancer.

[39]  L. Woelber,et al.  Prognostic Value of Pathological Resection Margin Distance in Squamous Cell Cancer of the Vulva , 2011, Annals of Surgical Oncology.

[40]  J. Bulten,et al.  New FIGO staging system of vulvar cancer indeed provides a better reflection of prognosis. , 2010, Gynecologic oncology.

[41]  A. V. D. Van Der Zee,et al.  Current controversies in the management of patients with early-stage vulvar cancer , 2010, Current opinion in oncology.

[42]  H. Hollema,et al.  Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study. , 2010, The Lancet. Oncology.

[43]  L. Selvaggi,et al.  Groin recurrence in carcinoma of the vulva: management and outcome. , 2010, European journal of cancer care.

[44]  H. Jacobsson,et al.  Presence of human papillomavirus (HPV) in vulvar squamous cell carcinoma (VSCC) and sentinel node. , 2010, Gynecologic oncology.

[45]  S. Beriwal,et al.  Does the number of nodes removed impact survival in vulvar cancer patients with node-negative disease? , 2010, Gynecologic oncology.

[46]  C. Burger,et al.  Recurrence Rate in Vulvar Carcinoma in Relation to Pathological Margin Distance , 2010, International Journal of Gynecologic Cancer.

[47]  N. Hacker,et al.  Berek & Hacker's gynecologic oncology , 2010 .

[48]  D. Nori,et al.  Radiation therapy compared with pelvic node resection for node-positive vulvar cancer: a randomized controlled trial. , 2010, Obstetrics and gynecology.

[49]  F. Gissi,et al.  Cisplatin and Vinorelbine Chemotherapy in Recurrent Vulvar Carcinoma , 2009, Oncology.

[50]  Christine H Chung,et al.  Human Papillomavirus in Head and Neck Cancer: Its Role in Pathogenesis and Clinical Implications , 2009, Clinical Cancer Research.

[51]  I. Vergote,et al.  Phase II study on paclitaxel in patients with recurrent, metastatic or locally advanced vulvar cancer not amenable to surgery or radiotherapy: a study of the EORTC-GCG (European Organisation for Research and Treatment of Cancer--Gynaecological Cancer Group). , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[52]  L. Massuger,et al.  Vulvar squamous cell carcinoma development after diagnosis of VIN increases with age. , 2009, European journal of cancer.

[53]  L. Woelber,et al.  Clinicopathological prognostic factors and patterns of recurrence in vulvar cancer. , 2009, Anticancer research.

[54]  A. Parwani.  Stage IA Vulvar Squamous Cell Carcinoma: An Analysis of Tumor Invasive Characteristics and Risk , 2009 .

[55]  H. Nieuwenhof,et al.  Review of squamous premalignant vulvar lesions. , 2008 .

[56]  Achim Schneider,et al.  Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[57]  A. Cmelak,et al.  Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. , 2008, Journal of the National Cancer Institute.

[58]  J. Epstein,et al.  Small Cell Carcinoma of the Prostate: A Morphologic and Immunohistochemical Study of 95 Cases , 2008, The American journal of surgical pathology.

[59]  E. Taioli,et al.  Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: Review and meta‐analysis , 2007, International journal of cancer.

[60]  P. Disaia,et al.  Margin distance and other clinico-pathologic prognostic factors in vulvar carcinoma: a multivariate analysis. , 2007, Gynecologic oncology.

[61]  A. Gadducci,et al.  Old and new perspectives in the management of high-risk, locally advanced or recurrent, and metastatic vulvar cancer. , 2006, Critical reviews in oncology/hematology.

[62]  E. Steiner,et al.  Surgical therapy of recurrent vulvar cancer. , 2006, American journal of obstetrics and gynecology.

[63]  G. D. de Bock,et al.  Patterns and frequency of recurrences of squamous cell carcinoma of the vulva. , 2006, Gynecologic oncology.

[64]  A. Bilchik,et al.  Lymphatic Mapping and Sentinel Node Analysis: Current Concepts and Applications , 2006, CA: a cancer journal for clinicians.

[65]  J. Rhie,et al.  Gluteal Fold V-Y Advancement Flap for Vulvar and Vaginal Reconstruction: A New Flap , 2006, Plastic and reconstructive surgery.

[66]  H. Hollema,et al.  Prediction of lymph node metastases in vulvar cancer: a review. , 2006, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

[67]  A. V. D. Van Der Zee,et al.  Surgery and radiotherapy in vulvar cancer. , 2006, Critical reviews in oncology/hematology.

[68]  J. Fonseca-Moutinho.  Recurrent vulvar cancer. , 2005, Clinical obstetrics and gynecology.

[69]  E. Steiner,et al.  Reconstructive surgery following resection of primary vulvar cancers. , 2005, Gynecologic oncology.

[70]  M. J. Webb,et al.  Long-term survival and disease recurrence in patients with primary squamous cell carcinoma of the vulva. , 2005, Gynecologic oncology.

[71]  D. Altomare,et al.  [Reconstruction with skin flaps of the posterior aspect of the thighs after total pelvic evisceration with removal of vulvo-perineal soft tissues in recurrent vulvar squamous carcinoma]. , 2005, I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.].

[72]  A. Obermair,et al.  Patterns of recurrence and disease-free survival in advanced squamous cell carcinoma of the vulva. , 2004, Gynecologic oncology.

[73]  J. Pintos,et al.  Prognostic significance of lymph node variables and human papillomavirus DNA in invasive vulvar carcinoma. , 2004, Gynecologic oncology.

[74]  H. Hollema,et al.  The value of routine follow‐up in patients treated for carcinoma of the vulva , 2003, Cancer.

[75]  N. Gleeson,et al.  Local and regional recurrence of vulval cancer: management dilemmas. , 2003, Best practice & research. Clinical obstetrics & gynaecology.

[76]  P. Blake.  Radiotherapy and chemoradiotherapy for carcinoma of the vulva. , 2003, Best practice & research. Clinical obstetrics & gynaecology.

[77]  P. Rose.  Local relapse in patients treated for squamous cell vulvar carcinoma: incidence and prognostic value. , 2003, Obstetrics and gynecology.

[78]  V. Tombolini,et al.  Radiotherapy alone and chemoirradiation in recurrent squamous cell carcinoma of the vulva. , 2003, Anticancer research.

[79]  C. R. Leemans,et al.  A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. , 2003, Cancer research.

[80]  H. Hollema,et al.  Vulvar carcinoma , 2002, Cancer.

[81]  E. Salom,et al.  Recurrent vulvar cancer , 2002, Current treatment options in oncology.

[82]  Dianne Miller,et al.  Vulvar squamous cell carcinoma in young women: a clinicopathologic study of 21 cases. , 2002, Gynecologic oncology.

[83]  M. Nooij,et al.  Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer. , 2001, Gynecologic oncology.

[84]  C. Haie-meder,et al.  Prognostic significance of epithelial disorders adjacent to invasive vulvar carcinomas. , 2001, Gynecologic oncology.

[85]  G. Montana,et al.  Preoperative chemo-radiation for carcinoma of the vulva with N2/N3 nodes: a gynecologic oncology group study. , 2000, International journal of radiation oncology, biology, physics.

[86]  A. Gadducci,et al.  Patterns of recurrence in patients with squamous cell carcinoma of the vulva , 2000, Cancer.

[87]  J. Velden.  Surgical interventions for early squamous cell carcinoma of the vulva. , 2000 .

[88]  G. Ronco,et al.  Recurrent squamous cell carcinoma of the vulva , 2000, Cancer.

[89]  P. Rose.  Skin bridge recurrences in vulvar cancer: frequency and management. , 1999, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

[90]  B. Monk,et al.  Interstitial brachytherapy in the treatment of advanced and recurrent vulvar cancer. , 1999, American journal of obstetrics and gynecology.

[91]  S. Modesitt,et al.  Vulvar Intraepithelial Neoplasia III: Occult Cancer and the Impact of Margin Status on Recurrence , 1998, Obstetrics and gynecology.

[92]  K. Gerszten,et al.  Isolated local recurrence in carcinoma of the vulva: Prognosis and implications for treatment , 1997 .

[93]  K. Bilek,et al.  Erfahrungen und Ergebnisse bei der Behandlung von Rezidiven des Vulvakarzinoms , 1997 .

[94]  E. Wilkinson,et al.  Prognostic factors in carcinoma of the vulva: a clinicopathologic and DNA flow cytometric study. , 1996, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[95]  B. Bundy,et al.  Sites of failure and times to failure in carcinoma of the vulva treated conservatively: a Gynecologic Oncology Group study. , 1996, American journal of obstetrics and gynecology.

[96]  A. Bracka,et al.  Vulvoperineal reconstruction after excision of anogenital multifocal intraepithelial neoplasia ("MIN"). , 1996, British journal of plastic surgery.

[97]  D. Gershenson,et al.  Pelvic exenteration for primary and recurrent vulvar cancer. , 1995, Gynecologic oncology.

[98]  B. Monk,et al.  Prognostic significance of human papillomavirus DNA in vulvar carcinoma , 1995 .

[99]  J. Monaghan,et al.  Prognostic significance of lymph node variables in squamous cell carcinoma of the vulva , 1994, Cancer.

[100]  H. van Tinteren,et al.  Human papillomavirus, lichen sclerosus, and squamous cell carcinoma of the vulva: detection and prognostic significance. , 1994, Gynecologic oncology.

[101]  D. Lampe,et al.  [Recurrent vulvar carcinoma at the Halle/S. University Gynecologic Clinic 1971-1990--diagnosis and results of therapy]. , 1994, Zentralblatt fur Gynakologie.

[102]  J. Bock,et al.  Human papillomavirus in vulvar squamous‐cell carcinoma and in normal vulvar tissues: A search for a possible impact of HPV on vulvar cancer prognosis , 1993, International journal of cancer.

[103]  A. Lopes,et al.  Recurrent squamous cell carcinoma of the vulva: a study of 73 cases. , 1993, Gynecologic oncology.

[104]  G. Chakalova,,et al.  The surgical management of recurrent carcinoma of the vulva. , 1993, European journal of gynaecological oncology.

[105]  G. Sutton,et al.  Recurrent squamous carcinoma of the vulva , 1992, American journal of obstetrics and gynecology.

[106]  L. Smith,et al.  Synchronous radiation and cytotoxic chemotherapy for locally advanced or recurrent squamous cancer of the vulva. , 1992, Gynecologic oncology.

[107]  W. Schmidt,et al.  Rezidive beim Vulvakarzinom - Behandlung, Erfahrungen und Ergebnisse , 1992 .

[108]  C. Villena-Heinsen,et al.  [Recurrence of vulvar cancer--treatment, experiences and results]. , 1992, Geburtshilfe und Frauenheilkunde.

[109]  T. Maggino,et al.  Carcinoma of the vulva: critical analysis of survival and treatment of recurrences. , 1992, European journal of gynaecological oncology.

[110]  E. Atkinson,et al.  Prognostic indicators for invasive carcinoma of the vulva. , 1991, Gynecologic oncology.

[111]  S. Wilczynski,et al.  Clinical and histologic features of vulvar carcinomas analyzed for human papillomavirus status: evidence that squamous cell carcinoma of the vulva has more than one etiology. , 1991, Human pathology.

[112]  J. Heaps,et al.  Surgical‐pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva , 1991, Gynecologic oncology.

[113]  J. Shepherd,et al.  A pilot study of chemo‐radiotherapy in advanced carcinoma of the vulva , 1991, British journal of obstetrics and gynaecology.

[114]  M. Hopkins,et al.  The surgical management of recurrent squamous cell carcinoma of the vulva , 1990, Obstetrics and gynecology.

[115]  O. Dalesio,et al.  Bleomycin, methotrexate, and CCNU in advanced inoperable squamous cell carcinoma of the vulva: a phase II study of the EORTC Gynaecological Cancer Cooperative Group (GCCG). , 1990, Gynecologic oncology.

[116]  B. Bundy,et al.  Radiation Therapy Versus Pelvic Node Resection for Carcinoma of the Vulva With Positive Groin Nodes , 1986, Obstetrics and gynecology.

[117]  N. Hacker,et al.  Essentials of Obstetrics and Gynecology , 1986 .

[118]  H. Frischbier,et al.  [Secondary vulvectomy treatment results in local recurrence of a vulvar carcinoma following electron irradiation]. , 1985, Geburtshilfe und Frauenheilkunde.

[119]  E. Simonsen.  Treatment of recurrent squamous cell carcinoma of the vulva. , 1984, Acta radiologica. Oncology.

[120]  N. Hacker,et al.  Management of Regional Lymph Nodes and Their Prognostic Influence in Vulvar Cancer , 1983, Obstetrics and gynecology.

[121]  W. Carr,et al.  Treatment of recurrent carcinoma of the vulva. , 1980, Gynecologic oncology.

[122]  W. Carr,et al.  Treatment of recurrent carcinoma of the vulva , 1979 .

[123]  R. Tomin,et al.  [VULVAR CARCINOMA]. , 1964, Srpski arhiv za celokupno lekarstvo.

[124]  M. R. Abell,et al.  Intraepithelial and infiltrative carcinoma of vulva: Bowen's type , 1961, Cancer.

[125]  M. Urrutia Ruiz.  Vulvar cancer , 1994 .